Ongoing research is exploring new molecular targets and targeted therapies for this challenging disease.
The interplay among genetics, social factors, cancer risk, and outcomes has been a focus of recent oncology research ... of ...
According to new research, 80% of patients with previously untreated or relapsed/refractory advanced-phase chronic myeloid leukemia (CML) -- including both accelerated or myeloid blast phases of the ...
According to researchers at The University of Texas MD Anderson Cancer Center, 80% of patients with previously untreated or ...
Before receiving treatment for acute myeloid leukemia, I made it a point to take advantage of all the resources that were ...
The researchers suggest certain refinements to the 2022 European LeukemiaNet classification model for patients aged 60 years ...
News Medical on MSN4d
Innovative triplet therapy shows encouraging results in advanced chronic myeloid leukemiaAccording to researchers at The University of Texas MD Anderson Cancer Center, 80% of patients with previously untreated or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback